-
Alternative name1
Anti-BRCA1, phospyhorylated (Ser1423) (Breast Cancer 1, Early Onset, Breast-Ovarian Cancer Susceptibility)
-
Alternative name2
BRCA1, phospyhorylated (Ser1423) (Breast Cancer 1, Early Onset, Breast-Ovarian Cancer Susceptibility)
-
Alternative name3
BRCA1, phospyhorylated (Ser1423) (Breast Cancer 1, Early Onset, Breast-Ovarian Cancer Susceptibility)
-
Alternative name4
BRCA1, phospyhorylated
-
Alternative name5
Anti -BRCA1, phospyhorylated (Ser1423) (Breast Cancer 1, Early Onset, Breast-Ovarian Cancer Susceptibility)
-
Other names
BRCA1; Breast cancer type 1 susceptibility protein; breast cancer type 1 susceptibility protein; OTTHUMP00000212143; OTTHUMP00000212147; OTTHUMP00000212148; OTTHUMP00000212149; OTTHUMP00000212150; OTTHUMP00000212151; OTTHUMP00000212155; RING finger protein 53; BRCA1/BRCA2-containing complex, subunit 1; breast and ovarian cancer susceptibility protein 1; breast and ovarian cancer sususceptibility protein; breast cancer 1, early onset; RING finger protein 53
-
Gene name
N/A
-
Gene name synonims
N/A
-
Other gene names
BRCA1; BRCA1; IRIS; PSCP; BRCAI; BRCC1; PNCA4; RNF53; BROVCA1; RNF53
-
Category
Antibodies
-
Clonality
Polyclonal
-
Immunoglobulin isotype
IgG
-
Clone
Polyclonal antibody
-
Host organism
Host: Rabbit; Source: Human
-
Species reactivity
Human
-
Specificity and cross reactivity
Recognizes human phospho-BRCA1 (Ser1423), Mr 200-220kD. Specificity was demonstrated by blocking the antibody with the immunizing peptide and treating the blot with lambda-phosphatase.
-
Purification method
Affinity Purified by Protein A affinity chromatography.
-
Form Appearance
Supplied as a liquid in 0.1M Tris glycine, pH 7.4, 0.15M sodium chloride, 0.05% sodium azide before the addition of glycerol to 30%.
-
Concentration
N/A
-
Storage and shipping
Store at 4 degrees Celsius for short term storage.. For long-term storage, For optimal long term storage, productone should be kept at -20 degrees Celsius. Aliquots are stable for at least 12 months productone should be stored at -20 degrees Celsius.. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
-
Tested for
Western Blot (WB)
-
Description
productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against. Properly used, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in. Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, they are inexpensive to manufacture and respectively to buy, the time needed for production is considerably shorter. Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions. To obtain more detailed information on productone, please, refer to the full product datasheet.
-
Advisory
In order to retain the quality and the affinity of productone unchanged, please, avoid cycles of freezing and thawing. For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube. Prior to use briefly centrifuge the vial to gather all the solution on the bottom.
-
Properties
If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.
-
French translation
anticorps
-
Gene target
-
Gene symbol
BRCA1, BRCA1P1
-
Short name
BRCA1, phospyhorylated (Ser1423) (Breast Cancer 1, Early Onset, Breast-Ovarian Cancer Susceptibility) Antibody
-
Technique
Antibody, antibodies against human proteins, antibodies for
-
Alternative name
breast cancer 1, early onset, phospyhorylated (Ser1423) (Breast Cancer 1, Early Onset, Breast-Ovarian Cancer Susceptibility) (antibody to-)
-
Alternative technique
antibodies
-
Alternative to gene target
breast cancer 1, early onset, BRCAI and BRCC1 and BROVCA1 and IRIS and PNCA4 and PPP1R53 and PSCP and RNF53, BRCA1 and IDBG-52172 and ENSG00000012048 and 672, androgen receptor binding, nuclei, Brca1 and IDBG-212218 and ENSMUSG00000017146 and 12189, BRCA1 and IDBG-640630 and ENSBTAG00000022520 and 353120
-
Tissue
breast, ovarian
-
Disease
cancer
-
